HEADER HYDROLASE, ALLERGEN 04-JAN-05 1YG9 TITLE THE STRUCTURE OF MUTANT (N93Q) OF BLA G 2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ASPARTIC PROTEASE BLA G 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: NIG2; COMPND 5 SYNONYM: ALLERGEN BLA G II; COMPND 6 EC: 3.4.23.-; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BLATTELLA GERMANICA; SOURCE 3 ORGANISM_COMMON: GERMAN COCKROACH; SOURCE 4 ORGANISM_TAXID: 6973; SOURCE 5 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: GS115; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PGAPZAC KEYWDS BLA G 2, ALLEGREN, HYDROLASE, ALLERGEN EXPDTA X-RAY DIFFRACTION AUTHOR M.LI,A.GUSTCHINA,S.WUENSCHMANN,A.POMES,A.WLODAWER REVDAT 7 20-OCT-21 1YG9 1 REMARK SEQADV HETSYN SHEET REVDAT 6 29-JUL-20 1YG9 1 COMPND REMARK SEQADV HETNAM REVDAT 6 2 1 LINK SITE ATOM REVDAT 5 13-JUL-11 1YG9 1 VERSN REVDAT 4 24-FEB-09 1YG9 1 VERSN REVDAT 3 09-MAY-06 1YG9 1 JRNL REVDAT 2 17-JAN-06 1YG9 1 JRNL REVDAT 1 22-MAR-05 1YG9 0 JRNL AUTH A.GUSTCHINA,M.LI,S.WUENSCHMANN,M.D.CHAPMAN,A.POMES, JRNL AUTH 2 A.WLODAWER JRNL TITL CRYSTAL STRUCTURE OF COCKROACH ALLERGEN BLA G 2, AN UNUSUAL JRNL TITL 2 ZINC BINDING ASPARTIC PROTEASE WITH A NOVEL MODE OF JRNL TITL 3 SELF-INHIBITION. JRNL REF J.MOL.BIOL. V. 348 433 2005 JRNL REFN ISSN 0022-2836 JRNL PMID 15811379 JRNL DOI 10.1016/J.JMB.2005.02.062 REMARK 2 REMARK 2 RESOLUTION. 1.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.7 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.181 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.180 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 4622 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 87692 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.159 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.159 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.188 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 3539 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 67631 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2547 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 43 REMARK 3 SOLVENT ATOMS : 478 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 3059.5 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 8 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 12361 REMARK 3 NUMBER OF RESTRAINTS : 10762 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 ANGLE DISTANCES (A) : 0.029 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.031 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.073 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.078 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.047 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.060 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC SCALING APPLIED BY THE REMARK 3 METHOD OF PARKIN, MOEZZI & HOPE, J.APPL.CRYST.28(1995)53-56 REMARK 4 REMARK 4 1YG9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-JAN-05. REMARK 100 THE DEPOSITION ID IS D_1000031479. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-MAR-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 94652 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.300 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05600 REMARK 200 FOR THE DATA SET : 17.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.35 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.49400 REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG8K, 10MM DTT AND 0.2M REMARK 280 MGACETATE, PH 5.8, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 70.80000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.30000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 70.80000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 19.30000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1262 LIES ON A SPECIAL POSITION. REMARK 375 HOH A1273 LIES ON A SPECIAL POSITION. REMARK 375 HOH A1341 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 N2 NAG A 601 O HOH A 1149 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE A 75A CB - CG - CD1 ANGL. DEV. = 4.8 DEGREES REMARK 500 PHE A 140 CB - CG - CD2 ANGL. DEV. = -5.4 DEGREES REMARK 500 VAL A 150 CG1 - CB - CG2 ANGL. DEV. = -14.7 DEGREES REMARK 500 ARG A 157 NE - CZ - NH2 ANGL. DEV. = 3.3 DEGREES REMARK 500 ARG A 193 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 ARG A 265 NE - CZ - NH2 ANGL. DEV. = -3.7 DEGREES REMARK 500 TYR A 274 CB - CG - CD2 ANGL. DEV. = -4.0 DEGREES REMARK 500 TYR A 274 CB - CG - CD1 ANGL. DEV. = 3.7 DEGREES REMARK 500 PHE A 305 CB - CG - CD1 ANGL. DEV. = -5.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 76 -51.82 68.86 REMARK 500 SER A 92 -128.25 51.85 REMARK 500 ILE A 220 -162.97 -126.60 REMARK 500 ARG A 242C -178.15 175.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 NAG A 601 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 155 ND1 REMARK 620 2 HIS A 161 NE2 97.6 REMARK 620 3 ASP A 303 OD1 98.4 117.9 REMARK 620 4 ASP A 307 OD1 110.9 123.1 105.6 REMARK 620 N 1 2 3 DBREF 1YG9 A 0 325 UNP P54958 ASP2_BLAGE 25 350 SEQADV 1YG9 GLY A -8 UNP P54958 CLONING ARTIFACT SEQADV 1YG9 ALA A -7 UNP P54958 CLONING ARTIFACT SEQADV 1YG9 SER A -6 UNP P54958 CLONING ARTIFACT SEQADV 1YG9 ILE A -5 UNP P54958 CLONING ARTIFACT SEQADV 1YG9 GLN A 93 UNP P54958 ASN 117 ENGINEERED MUTATION SEQADV 1YG9 CSX A 289 UNP P54958 CYS 316 MODIFIED RESIDUE SEQRES 1 A 330 GLY ALA SER ILE VAL PRO LEU TYR LYS LEU VAL HIS VAL SEQRES 2 A 330 PHE ILE ASN THR GLN TYR ALA GLY ILE THR LYS ILE GLY SEQRES 3 A 330 ASN GLN ASN PHE LEU THR VAL PHE ASP SER THR SER CYS SEQRES 4 A 330 ASN VAL VAL VAL ALA SER GLN GLU CYS VAL GLY GLY ALA SEQRES 5 A 330 CYS VAL CYS PRO ASN LEU GLN LYS TYR GLU LYS LEU LYS SEQRES 6 A 330 PRO LYS TYR ILE SER ASP GLY ASN VAL GLN VAL LYS PHE SEQRES 7 A 330 PHE ASP THR GLY SER ALA VAL GLY ARG GLY ILE GLU ASP SEQRES 8 A 330 SER LEU THR ILE SER GLN LEU THR THR SER GLN GLN ASP SEQRES 9 A 330 ILE VAL LEU ALA ASP GLU LEU SER GLN GLU VAL CYS ILE SEQRES 10 A 330 LEU SER ALA ASP VAL VAL VAL GLY ILE ALA ALA PRO GLY SEQRES 11 A 330 CYS PRO ASN ALA LEU LYS GLY LYS THR VAL LEU GLU ASN SEQRES 12 A 330 PHE VAL GLU GLU ASN LEU ILE ALA PRO VAL PHE SER ILE SEQRES 13 A 330 HIS HIS ALA ARG PHE GLN ASP GLY GLU HIS PHE GLY GLU SEQRES 14 A 330 ILE ILE PHE GLY GLY SER ASP TRP LYS TYR VAL ASP GLY SEQRES 15 A 330 GLU PHE THR TYR VAL PRO LEU VAL GLY ASP ASP SER TRP SEQRES 16 A 330 LYS PHE ARG LEU ASP GLY VAL LYS ILE GLY ASP THR THR SEQRES 17 A 330 VAL ALA PRO ALA GLY THR GLN ALA ILE ILE ASP THR SER SEQRES 18 A 330 LYS ALA ILE ILE VAL GLY PRO LYS ALA TYR VAL ASN PRO SEQRES 19 A 330 ILE ASN GLU ALA ILE GLY CYS VAL VAL GLU LYS THR THR SEQRES 20 A 330 THR ARG ARG ILE CYS LYS LEU ASP CYS SER LYS ILE PRO SEQRES 21 A 330 SER LEU PRO ASP VAL THR PHE VAL ILE ASN GLY ARG ASN SEQRES 22 A 330 PHE ASN ILE SER SER GLN TYR TYR ILE GLN GLN ASN GLY SEQRES 23 A 330 ASN LEU CYS TYR SER GLY PHE GLN PRO CSX GLY HIS SER SEQRES 24 A 330 ASP HIS PHE PHE ILE GLY ASP PHE PHE VAL ASP HIS TYR SEQRES 25 A 330 TYR SER GLU PHE ASN TRP GLU ASN LYS THR MET GLY PHE SEQRES 26 A 330 GLY ARG SER VAL GLU MODRES 1YG9 ASN A 268 ASN GLYCOSYLATION SITE MODRES 1YG9 ASN A 317 ASN GLYCOSYLATION SITE MODRES 1YG9 CSX A 289 CYS S-OXY CYSTEINE HET CSX A 289 7 HET NAG B 1 14 HET NAG B 2 14 HET NAG A 601 14 HET ZN A 401 1 HETNAM CSX S-OXY CYSTEINE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM ZN ZINC ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 1 CSX C3 H7 N O3 S FORMUL 2 NAG 3(C8 H15 N O6) FORMUL 4 ZN ZN 2+ FORMUL 5 HOH *478(H2 O) HELIX 1 1 GLY A 47 CYS A 51A 5 6 HELIX 2 2 GLN A 110 LEU A 115 1 6 HELIX 3 3 THR A 135 GLU A 143 1 9 HELIX 4 4 ASP A 171 LYS A 173 5 3 HELIX 5 5 LYS A 225 GLY A 236 1 12 HELIX 6 6 ASP A 248 LEU A 255 5 8 HELIX 7 7 SER A 270 TYR A 274 1 5 HELIX 8 8 GLY A 302 ASP A 307 1 6 SHEET 1 A 6 VAL A 2 ILE A 6 0 SHEET 2 A 6 HIS A 161 PHE A 167 -1 O GLY A 163 N ILE A 6 SHEET 3 A 6 VAL A 150 ARG A 157 -1 N SER A 152 O ILE A 166 SHEET 4 A 6 TYR A 309 ASN A 314 -1 O PHE A 313 N PHE A 151 SHEET 5 A 6 THR A 319 SER A 325 -1 O GLY A 321 N GLU A 312 SHEET 6 A 6 VAL A 175 PRO A 183 -1 N ASP A 176 O ARG A 324 SHEET 1 B 9 LYS A 65 TYR A 66 0 SHEET 2 B 9 VAL A 71 PHE A 75 0 SHEET 3 B 9 ALA A 15 ILE A 20 0 SHEET 4 B 9 GLN A 25 ASP A 32 -1 O THR A 29 N GLY A 16 SHEET 5 B 9 VAL A 119 GLY A 122 1 O VAL A 121 N VAL A 30 SHEET 6 B 9 VAL A 38 ALA A 41 -1 N VAL A 39 O VAL A 120 SHEET 7 B 9 LEU A 94 LEU A 107 1 O VAL A 102 N VAL A 38 SHEET 8 B 9 GLY A 78 ILE A 91 -1 N ARG A 83 O LEU A 103 SHEET 9 B 9 VAL A 71 PHE A 75 -1 N VAL A 71 O GLY A 82 SHEET 1 C 5 PHE A 192 ARG A 193 0 SHEET 2 C 5 GLN A 211 ILE A 214 -1 O ALA A 212 N PHE A 192 SHEET 3 C 5 PHE A 299 ILE A 301 1 O ILE A 301 N ILE A 213 SHEET 4 C 5 ILE A 221 PRO A 224 -1 N VAL A 222 O PHE A 300 SHEET 5 C 5 PHE A 286 CSX A 289 1 O GLN A 287 N ILE A 221 SHEET 1 D 4 THR A 202 ALA A 205 0 SHEET 2 D 4 GLY A 196 ILE A 199 -1 N VAL A 197 O VAL A 204 SHEET 3 D 4 VAL A 258 ILE A 262 -1 O VAL A 261 N GLY A 196 SHEET 4 D 4 ARG A 265 ILE A 269 -1 O PHE A 267 N PHE A 260 SHEET 1 E 3 VAL A 238 LYS A 241 0 SHEET 2 E 3 LEU A 281 SER A 284 -1 O SER A 284 N CYS A 245 SHEET 3 E 3 ILE A 275 ASN A 278 -1 N GLN A 276 O TYR A 283 SSBOND 1 CYS A 36 CYS A 127 1555 1555 2.01 SSBOND 2 CYS A 45 CYS A 50 1555 1555 2.04 SSBOND 3 CYS A 51A CYS A 113 1555 1555 2.00 SSBOND 4 CYS A 237 CYS A 245 1555 1555 2.10 SSBOND 5 CYS A 249 CYS A 282 1555 1555 2.05 LINK ND2 ASN A 268 C1 NAG B 1 1555 1555 1.46 LINK C PRO A 288 N CSX A 289 1555 1555 1.32 LINK C CSX A 289 N GLY A 290 1555 1555 1.33 LINK ND2 ASN A 317 C1 NAG A 601 1555 1555 1.48 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.43 LINK ND1 HIS A 155 ZN ZN A 401 1555 1555 2.05 LINK NE2 HIS A 161 ZN ZN A 401 1555 1555 1.97 LINK OD1 ASP A 303 ZN ZN A 401 1555 1555 1.95 LINK OD1 ASP A 307 ZN ZN A 401 1555 1555 1.91 CRYST1 141.600 38.600 71.500 90.00 100.90 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007062 0.000000 0.001360 0.00000 SCALE2 0.000000 0.025907 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014243 0.00000